Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Silo Pharma宣布根据纳斯达克规则以市价完成210万美元的注册直接发行
Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Silo Pharma宣布根据纳斯达克规则以市价完成210万美元的注册直接发行
使用浏览器的分享功能,分享给你的好友吧